ISSN 1662-4009 (online)

ey0016.7-11 | Clinical Guidance | ESPEYB16

7.11. Gonadal function and pubertal development in patients with Silver-Russell syndrome

WJ Goedegebuure , CCJ Smeets , JS Renes , YB de Rijke , ACS Hokken-Koelega

To read the full abstract: Hum Reprod. 2018 Nov 1;33(11):2122–2130This longitudinal study of 31 patients (14 males) with Silver-Russell syndrome (SRS) and 123 non-SRS small-for-gestational-age (SGA) patients (65 males) shows that Sertoli cell dysfunction is more common in SRS males, with 11p15 loss of methylation (LOM), but gonadal function seems to be unaffected in SRS females....

ey0020.2-4 | Important for Clinical Practice | ESPEYB20

2.4. Childhood growth hormone treatment and metabolic and cardiovascular risk in adults born small for gestational age after growth hormone cessation in the Netherlands: a 12-year follow-up study

WJ Goedegebuure , M van der Steen , CCJ Smeets , ACS Hokken-Koelega

Brief summary: In this longitudinal study, the authors investigated the metabolic and cardiovascular health profile of 167 adults born SGA and previously treated with rhGH during a period of 12 years after therapy discontinuation. No relevant differences were found in treated SGA subjects compared with untreated SGA adults or adults born appropriate for gestational age (AGA), thus suggesting long-term metabolic and cardiovascular safety of rhGH treatment in short SGA children....

ey0021.4-5 | Important for Clinical Practice | ESPEYB21

4.5. Cerebrovascular abnormalities in adults born SGA at 12 years after growth hormone cessation compared to controls

DJ Dorrepaal , WJ Goedegebuure , L Smagge , M van der Steen , A van der Lugt , ACS Hokken-Koelega

Brief Summary: This single-center, prospective study used brain MRI to assess the prevalence of cerebrovascular abnormalities in a large cohort of adult patients born SGA and treated with GH during childhood, 12 years after rhGH treatment cessation. GH treatment was not associated with a higher incidence of aneurysms, intracerebral hemorrhages, microbleeds or other vascular abnormalities.The French population-based cohort of the Safety and Appropriatenes...

ey0021.15-9 | Artificial Intelligence | ESPEYB21

15.9. Computer-aided facial analysis as a tool to identify patients with Silver-Russell syndrome and Prader-Willi syndrome

S Ciancia , WJ Goedegebuure , LN Grootjen , ACS Hokken-Koelega , GF Kerkhof , DCM. van der Kaay

In Brief: The authors tested the diagnostic ability of the Face2Gene app in 23 children with a clinical or genetically confirmed diagnosis of Silver-Russell syndrome (SRS) and 29 children with genetically confirmed Prader-Willi syndrome (PWS). When combined with careful routine clinical history and examination, the Face2Gene app can be a useful diagnostic tool.Among PWS patients, Face2Gene calculated the top 1, top 5, and top 10 sensitivities to be 76%, ...